gamma-aminobutyric acid has been researched along with Dysesthesia in 27 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a high incidence of oral mucosal dysesthesia occurring in patients on a pilot study of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa) in combination with paclitaxel (Taxol) and external beam radiation therapy for the treatment of locally advanced squamous cell carcinoma of the head and neck." | 9.13 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "Development of "burning"-type oral dysesthesia occurred in patients treated with the combination of gefitinib, paclitaxel, and external beam radiation of the oral tongue." | 9.13 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "The objective of this study was to compare the efficacy and tolerability of gabapentin and amitriptyline monotherapy in painful diabetic neuropathy." | 9.09 | Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. ( Buffa, C; Chiroli, S; Dallocchio, C; Mazzarello, P, 2000) |
| "The perception of pain or paresthesia was evaluated as 0--Normal (no pain or paresthesia), 1--Mild, 2--Moderate, 3--Severe at baseline and after thirty days of treatment." | 6.74 | Efficacy of gabapentin versus diclofenac in the treatment of chest pain and paresthesia in patients with sternotomy. ( Biyik, I; Ergene, O; Gülcüler, M; Karabiga, M; Tayyar, N, 2009) |
| "In gabapentin group, mean pain and paresthesia scores regressed from 2." | 6.74 | Efficacy of gabapentin versus diclofenac in the treatment of chest pain and paresthesia in patients with sternotomy. ( Biyik, I; Ergene, O; Gülcüler, M; Karabiga, M; Tayyar, N, 2009) |
| "Chronic post-sternotomy chest pain and paresthesia (PCPP) are frequently seen and reduce the quality of life." | 6.74 | Efficacy of gabapentin versus diclofenac in the treatment of chest pain and paresthesia in patients with sternotomy. ( Biyik, I; Ergene, O; Gülcüler, M; Karabiga, M; Tayyar, N, 2009) |
| "The patients without grade 3 oral dysesthesia received less than 50 Gy radiation to the oral tongue." | 6.73 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "This dysesthesia was improved by the use of gabapentin." | 6.73 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "Gabapentin (Neurontin) was administered to 2 patients as a treatment for painful mucosal neuropathy." | 6.73 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "All had stage III/IVA-B squamous cell carcinoma of the head and neck." | 6.73 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "Development of "burning"-type oral dysesthesia occurred in patients treated with the combination of gefitinib, paclitaxel, and external beam radiation of the oral tongue." | 6.73 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "The oral dysesthesia was exacerbated by the ingestion of neutral pH liquids such as water." | 6.73 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "Decreases in paresthesia scores also were in favor of gabapentin (1." | 6.69 | Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. ( Buffa, C; Chiroli, S; Dallocchio, C; Mazzarello, P, 2000) |
| "Paclitaxel can cause an acute pain syndrome (P-APS), considered to be an acute form of neuropathy and chronic chemotherapy-induced peripheral neuropathy (CIPN)." | 5.22 | Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial. ( Atherton, PJ; Lafky, J; Loprinzi, CL; Pachman, DR; Ruddy, KJ; Seisler, D; Shinde, SS; Soori, G, 2016) |
| "To report a high incidence of oral mucosal dysesthesia occurring in patients on a pilot study of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa) in combination with paclitaxel (Taxol) and external beam radiation therapy for the treatment of locally advanced squamous cell carcinoma of the head and neck." | 5.13 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "Development of "burning"-type oral dysesthesia occurred in patients treated with the combination of gefitinib, paclitaxel, and external beam radiation of the oral tongue." | 5.13 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "The objective of this study was to compare the efficacy and tolerability of gabapentin and amitriptyline monotherapy in painful diabetic neuropathy." | 5.09 | Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. ( Buffa, C; Chiroli, S; Dallocchio, C; Mazzarello, P, 2000) |
| " A dramatic response of the severe dysesthesias to amitriptyline and gabapentin is described." | 3.71 | Late-onset GM2 gangliosidosis presenting as burning dysesthesias. ( Banwell, BL; Chow, GC; Clarke, JT, 2001) |
| "Paclitaxel can cause an acute pain syndrome (P-APS), considered to be an acute form of neuropathy and chronic chemotherapy-induced peripheral neuropathy (CIPN)." | 2.82 | Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial. ( Atherton, PJ; Lafky, J; Loprinzi, CL; Pachman, DR; Ruddy, KJ; Seisler, D; Shinde, SS; Soori, G, 2016) |
| "The perception of pain or paresthesia was evaluated as 0--Normal (no pain or paresthesia), 1--Mild, 2--Moderate, 3--Severe at baseline and after thirty days of treatment." | 2.74 | Efficacy of gabapentin versus diclofenac in the treatment of chest pain and paresthesia in patients with sternotomy. ( Biyik, I; Ergene, O; Gülcüler, M; Karabiga, M; Tayyar, N, 2009) |
| "In gabapentin group, mean pain and paresthesia scores regressed from 2." | 2.74 | Efficacy of gabapentin versus diclofenac in the treatment of chest pain and paresthesia in patients with sternotomy. ( Biyik, I; Ergene, O; Gülcüler, M; Karabiga, M; Tayyar, N, 2009) |
| "Chronic post-sternotomy chest pain and paresthesia (PCPP) are frequently seen and reduce the quality of life." | 2.74 | Efficacy of gabapentin versus diclofenac in the treatment of chest pain and paresthesia in patients with sternotomy. ( Biyik, I; Ergene, O; Gülcüler, M; Karabiga, M; Tayyar, N, 2009) |
| "All had stage III/IVA-B squamous cell carcinoma of the head and neck." | 2.73 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "The patients without grade 3 oral dysesthesia received less than 50 Gy radiation to the oral tongue." | 2.73 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "Development of "burning"-type oral dysesthesia occurred in patients treated with the combination of gefitinib, paclitaxel, and external beam radiation of the oral tongue." | 2.73 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "The oral dysesthesia was exacerbated by the ingestion of neutral pH liquids such as water." | 2.73 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "This dysesthesia was improved by the use of gabapentin." | 2.73 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "Gabapentin (Neurontin) was administered to 2 patients as a treatment for painful mucosal neuropathy." | 2.73 | High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers. ( Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C, 2008) |
| "Gabapentin was prescribed to 60 consecutive out-patients with refractory pain persisting at four weeks or more after thoracic surgery or trauma." | 2.72 | The use of gabapentin for post-operative and post-traumatic pain in thoracic surgery patients. ( Lee, TW; Sihoe, AD; Thung, KH; Wan, IY; Yim, AP, 2006) |
| "Chest wall paresthesia distinguishable from wound pain was relieved in 24 (75." | 2.72 | The use of gabapentin for post-operative and post-traumatic pain in thoracic surgery patients. ( Lee, TW; Sihoe, AD; Thung, KH; Wan, IY; Yim, AP, 2006) |
| "The mean duration of pre-treatment refractory pain was 5." | 2.72 | The use of gabapentin for post-operative and post-traumatic pain in thoracic surgery patients. ( Lee, TW; Sihoe, AD; Thung, KH; Wan, IY; Yim, AP, 2006) |
| "Decreases in paresthesia scores also were in favor of gabapentin (1." | 2.69 | Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. ( Buffa, C; Chiroli, S; Dallocchio, C; Mazzarello, P, 2000) |
| "Patients with scalp dysesthesia also had abnormal cervical spine images." | 1.39 | Scalp dysesthesia related to cervical spine disease. ( English, JC; Thornsberry, LA, 2013) |
| "Scalp dysesthesia is characterized by abnormal sensations of the scalp in the absence of any other unusual physical examination findings." | 1.39 | Scalp dysesthesia related to cervical spine disease. ( English, JC; Thornsberry, LA, 2013) |
| "Neuropathic and/or neuralgic facial pain occurred in 50% (n = 7)." | 1.35 | The trigeminal trophic syndrome: an unusual cause of face pain, dysaesthesias, anaesthesia and skin/soft tissue lesions. ( Garza, I, 2008) |
| "Three of 71 patients had myoclonus with GBP doses ranging from 9 mg/kg to 20 mg/kg and within 4 months of treatment onset." | 1.33 | Gabapentin-induced myoclonus in end-stage renal disease. ( Bell, WL; Glenn, DG; O'Donovan, CA; Zhang, C, 2005) |
| "Myoclonus was characterized as multifocal, involving all extremities in the three patients." | 1.33 | Gabapentin-induced myoclonus in end-stage renal disease. ( Bell, WL; Glenn, DG; O'Donovan, CA; Zhang, C, 2005) |
| "Two patients experienced paresthesias in all digits of the hands, glove-like numbness of the hands and forearm, weakness (unable to open jars), hand clumsiness, upper extremity coldness, fullness or tightness, deep aching pain, and other signs and symptoms consistent with T4 syndrome." | 1.33 | Clinical presentation, quantitative sensory testing, and therapy of 2 patients with fourth thoracic syndrome. ( Mellick, GA; Mellick, LB, 2006) |
| "GBP increases the risk of myoclonus in ESRD." | 1.33 | Gabapentin-induced myoclonus in end-stage renal disease. ( Bell, WL; Glenn, DG; O'Donovan, CA; Zhang, C, 2005) |
| "A dramatic response of the severe dysesthesias to amitriptyline and gabapentin is described." | 1.31 | Late-onset GM2 gangliosidosis presenting as burning dysesthesias. ( Banwell, BL; Chow, GC; Clarke, JT, 2001) |
| "Treatment with gabapentin was associated with a substantial decrease in pain, which relapsed after tapering the medication." | 1.30 | Gabapentin for the treatment of dysesthetic pain after reconstructive surgery. ( Otley, CC, 1999) |
| "Gabapentin is a new, novel antiepileptic drug helpful in the management of other pain states." | 1.30 | Gabapentin for the treatment of dysesthetic pain after reconstructive surgery. ( Otley, CC, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.70) | 18.2507 |
| 2000's | 15 (55.56) | 29.6817 |
| 2010's | 11 (40.74) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagandla, K | 1 |
| De, S | 1 |
| Sarifakioglu, E | 1 |
| Onur, O | 1 |
| Thornsberry, LA | 1 |
| English, JC | 1 |
| Shinde, SS | 1 |
| Seisler, D | 1 |
| Soori, G | 1 |
| Atherton, PJ | 1 |
| Pachman, DR | 1 |
| Lafky, J | 1 |
| Ruddy, KJ | 1 |
| Loprinzi, CL | 1 |
| Hoeijmakers, JG | 1 |
| Faber, CG | 1 |
| Miedema, CJ | 1 |
| Merkies, IS | 1 |
| Vles, JS | 1 |
| Garza, I | 1 |
| Sharp, H | 1 |
| Morris, JC | 1 |
| Van Waes, C | 1 |
| Gius, D | 1 |
| Cooley-Zgela, T | 1 |
| Singh, AK | 1 |
| Biyik, I | 1 |
| Gülcüler, M | 1 |
| Karabiga, M | 1 |
| Ergene, O | 1 |
| Tayyar, N | 1 |
| Lennertz, RC | 1 |
| Tsunozaki, M | 1 |
| Bautista, DM | 1 |
| Stucky, CL | 1 |
| Ong, OL | 1 |
| Churchyard, AC | 1 |
| New, PW | 1 |
| Böhm, J | 1 |
| Visser, LH | 1 |
| Lehmann, TN | 1 |
| López-López, J | 1 |
| Estrugo-Devesa, A | 1 |
| Jané-Salas, E | 1 |
| Segura-Egea, JJ | 1 |
| Tan, IL | 1 |
| Polydefkis, MJ | 1 |
| Ebenezer, GJ | 1 |
| Hauer, P | 1 |
| McArthur, JC | 1 |
| Gerlinger, I | 1 |
| Vogel, LC | 1 |
| Anderson, CJ | 1 |
| Lotery, HE | 1 |
| McClure, N | 1 |
| Galask, RP | 1 |
| Wepner, U | 1 |
| Zhang, C | 1 |
| Glenn, DG | 1 |
| Bell, WL | 1 |
| O'Donovan, CA | 1 |
| Sihoe, AD | 1 |
| Lee, TW | 1 |
| Wan, IY | 1 |
| Thung, KH | 1 |
| Yim, AP | 1 |
| Mellick, GA | 1 |
| Mellick, LB | 1 |
| Pandey, CK | 1 |
| Patra, P | 1 |
| Pant, KC | 1 |
| Singh, PK | 1 |
| Celebi, N | 1 |
| Sahin, A | 1 |
| Canbay, O | 1 |
| Uzümcügil, F | 1 |
| Aypar, U | 1 |
| Loosemore, MP | 1 |
| Bordeaux, JS | 1 |
| Bernhard, JD | 1 |
| Otley, CC | 1 |
| Dallocchio, C | 1 |
| Buffa, C | 1 |
| Mazzarello, P | 1 |
| Chiroli, S | 1 |
| Trinka, E | 1 |
| Niedermüller, U | 1 |
| Thaler, C | 1 |
| Doering, S | 1 |
| Moroder, T | 1 |
| Ladurner, G | 1 |
| Bauer, G | 1 |
| Chow, GC | 1 |
| Clarke, JT | 1 |
| Banwell, BL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Phase I Dose Escalation Study Of The EGFR Tyrosine Kinase Inhibitor Gefitinib (Iressa) Combined With Paclitaxel (Taxol) And External Beam Radiation Therapy In Patients With Advanced Squamous Cell Carcinoma Of The Head And Neck (SCCHN)[NCT00083057] | Phase 1 | 30 participants (Anticipated) | Interventional | 2004-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for gamma-aminobutyric acid and Dysesthesia
| Article | Year |
|---|---|
Restless legs syndrome: pathophysiology and modern management.
Topics: Amines; Anemia; Anticonvulsants; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Dopamine Agon | 2013 |
[Burning sensation in oral cavity--burning mouth syndrome in everyday medical practice].
Topics: Acetamides; Amines; Anti-Anxiety Agents; Antidepressive Agents; Antioxidants; Burning Mouth Syndrome | 2012 |
5 trials available for gamma-aminobutyric acid and Dysesthesia
| Article | Year |
|---|---|
Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial.
Topics: Acute Pain; Adult; Aged; Amines; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric | 2016 |
High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers.
Topics: Adult; Aged; Amines; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squ | 2008 |
Efficacy of gabapentin versus diclofenac in the treatment of chest pain and paresthesia in patients with sternotomy.
Topics: Adult; Aged; Aged, 80 and over; Amines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Chest P | 2009 |
The use of gabapentin for post-operative and post-traumatic pain in thoracic surgery patients.
Topics: Adult; Aged; Aged, 80 and over; Amines; Analgesics; Cyclohexanecarboxylic Acids; Female; Gabapentin; | 2006 |
Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study.
Topics: Acetates; Aged; Aged, 80 and over; Amines; Amitriptyline; Analgesics; Ataxia; Cyclohexanecarboxylic | 2000 |
20 other studies available for gamma-aminobutyric acid and Dysesthesia
| Article | Year |
|---|---|
Women with scalp dysesthesia treated with pregabalin.
Topics: Adult; Analgesics; Female; gamma-Aminobutyric Acid; Humans; Pain; Paresthesia; Pregabalin; Pruritus; | 2013 |
Scalp dysesthesia related to cervical spine disease.
Topics: Adult; Aged; Aged, 80 and over; Amines; Analgesics; Cervical Vertebrae; Cyclohexanecarboxylic Acids; | 2013 |
Small Fiber Neuropathy in Children: Two Case Reports Illustrating the Importance of Recognition.
Topics: Adolescent; Amines; Analgesics; Biopsy; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Eryth | 2016 |
The trigeminal trophic syndrome: an unusual cause of face pain, dysaesthesias, anaesthesia and skin/soft tissue lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amines; Child; Cyclohexanecarboxylic Acids; Erythema; Fa | 2008 |
Physiological basis of tingling paresthesia evoked by hydroxy-alpha-sanshool.
Topics: Action Potentials; Amides; Animals; Animals, Newborn; Capsaicin; Cells, Cultured; gamma-Aminobutyric | 2010 |
The importance of early diagnosis of herpes zoster myelitis.
Topics: Acyclovir; Aged; Amines; Analgesics; Anti-Inflammatory Agents; Antiviral Agents; Cyclohexanecarboxyl | 2010 |
High-resolution sonography of posttraumatic neuroma of the superficial radial nerve.
Topics: Analgesics; Bone Plates; Female; gamma-Aminobutyric Acid; Humans; Middle Aged; Neuroma; Neurosurgica | 2011 |
Inferior alveolar nerve injury resulting from overextension of an endodontic sealer: non-surgical management using the GABA analogue pregabalin.
Topics: Adult; Analgesics; Anti-Inflammatory Agents; Epoxy Resins; Female; Follow-Up Studies; Foreign Bodies | 2012 |
Peripheral nerve toxic effects of nitrofurantoin.
Topics: Amines; Analgesics; Anti-Infective Agents, Urinary; Biopsy; Cyclohexanecarboxylic Acids; Cystitis, I | 2012 |
Self-injurious behavior in children and adolescents with spinal cord injuries.
Topics: Acetates; Adolescent; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Fe | 2002 |
Vulvodynia.
Topics: Acetates; Amines; Anticonvulsants; Antidepressive Agents, Tricyclic; Biofeedback, Psychology; Chroni | 2004 |
[Evidence-based management of diabetic polyneuropathy. "Burning feet" alarm signal].
Topics: Amines; Combined Modality Therapy; Cyclohexanecarboxylic Acids; Diabetic Foot; Diabetic Neuropathies | 2004 |
Gabapentin-induced myoclonus in end-stage renal disease.
Topics: Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric | 2005 |
Clinical presentation, quantitative sensory testing, and therapy of 2 patients with fourth thoracic syndrome.
Topics: Adult; Amines; Analgesics; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; | 2006 |
Gabapentin for the treatment of refractory dysesthetic pain after open cholecystectomy.
Topics: Amines; Analgesics; Cholecystectomy; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Aci | 2006 |
Abdominal pain related to mitochondrial neurogastrointestinal encephalomyopathy syndrome may benefit from splanchnic nerve blockade.
Topics: Abdominal Pain; Adolescent; Amines; Analgesics; Anesthetics, Local; Cyclohexanecarboxylic Acids; Ele | 2006 |
Gabapentin treatment for notalgia paresthetica, a common isolated peripheral sensory neuropathy.
Topics: Aged, 80 and over; Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric A | 2007 |
Gabapentin for the treatment of dysesthetic pain after reconstructive surgery.
Topics: Acetates; Aged; Amines; Analgesics; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobuty | 1999 |
Gabapentin-induced mood changes with hypomanic features in adults.
Topics: Acetates; Adult; Affect; Amines; Anticonvulsants; Chlamydia Infections; Cyclohexanecarboxylic Acids; | 2000 |
Late-onset GM2 gangliosidosis presenting as burning dysesthesias.
Topics: Acetates; Adolescent; Amines; Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Cyclohexa | 2001 |